ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Seelos Receives FDA May Proceed Notice to Initiate a Trial of SLS-005 in ALS
August 14, 2020Seelos Therapeutics received notice from the Food and Drug Administration (FDA) that the company may proceed with initiating a Phase IIb/III trial studying SLS-005 (trehalose) for the treatment of Amyotrophic lateral sclerosis ... -
Seelos Receives Rare Pediatric Disease Designation for Trehalose in Sanfilippo Syndrome
May 21, 2020Seelos Therapeutics has been granted Rare Pediatric Disease Designation (RPDD) for SLS-005 in Sanfilippo syndrome from the U.S. Food and Drug Administration (FDA).
Pharma Sources Insight January 2025
